Chugai Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	102,935	86,522	73,254	62,351	42,013	53,339
Market Cap Growth	45.33%	18.11%	17.49%	48.41%	-21.23%	-39.15%
Enterprise Value	96,728	80,893	67,877	57,961	37,878	49,894
Last Close Price	31.21	26.27	21.97	18.85	12.67	16.36
PE Ratio	37.19	31.26	29.74	27.00	14.80	20.27
PS Ratio	12.83	10.78	9.84	7.91	4.40	6.14
PB Ratio	7.97	6.70	6.06	5.41	3.89	5.17
P/TBV Ratio	8.19	6.88	6.11	5.47	3.96	5.27
P/FCF Ratio	52.06	43.76	29.00	26.01	30.53	28.74
P/OCF Ratio	41.78	35.12	25.73	21.44	22.70	21.96
EV/Sales Ratio	12.14	10.08	9.12	7.35	3.97	5.75
EV/EBITDA Ratio	24.52	20.57	18.60	17.35	8.85	12.69
EV/EBIT Ratio	25.87	21.49	19.69	18.60	9.37	13.62
EV/FCF Ratio	48.92	40.91	26.87	24.17	27.52	26.89
Debt / Equity Ratio	-	-	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	-	-	0.02	0.03	0.02	0.04
Debt / FCF Ratio	-	-	0.03	0.04	0.08	0.08
Net Debt / Equity Ratio	-0.48	-0.48	-0.52	-0.45	-0.34	-0.38
Net Debt / EBITDA Ratio	-1.59	-1.59	-1.72	-1.54	-0.87	-1.01
Net Debt / FCF Ratio	-3.16	-3.16	-2.48	-2.15	-2.69	-2.13
Asset Turnover	0.54	0.54	0.56	0.59	0.74	0.72
Inventory Turnover	1.41	1.41	1.32	1.46	1.90	1.72
Quick Ratio	3.46	3.46	4.59	3.68	2.40	2.53
Current Ratio	4.24	4.24	5.53	4.74	3.15	3.25
Return on Equity (ROE)	22.10%	22.10%	21.96%	21.34%	28.67%	27.95%
Return on Assets (ROA)	15.77%	15.77%	16.36%	14.44%	19.56%	19.01%
Return on Invested Capital (ROIC)	41.72%	43.67%	42.57%	35.09%	45.09%	45.33%
Return on Capital Employed (ROCE)	28.70%	28.70%	28.30%	26.70%	36.90%	34.80%
Earnings Yield	2.69%	3.20%	3.36%	3.70%	6.76%	4.93%
FCF Yield	1.92%	2.28%	3.45%	3.84%	3.28%	3.48%
Dividend Yield	5.78%	2.96%	2.84%	3.01%	4.67%	4.04%
Payout Ratio	107.32%	68.99%	34.40%	40.43%	36.91%	32.56%
Buyback Yield / Dilution	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%
Total Shareholder Return	5.37%	2.96%	2.83%	3.00%	4.66%	4.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.